Secretary of biotechnology development headquarter announced the increased number of biotechnology accelerators in the current year.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Mostafa Ghanei, secretary of biotechnology development headquarter, pointed out the necessity of increasing the number of biotechnology accelerators in the country, stating: accelerators are companies that create new investment ideas. These companies help idea owners accurately define their sample and provide a suitable primary sample of the product or service as a kind of innovation in the industry.

He expressed that accelerators are effective in development of activities of enterprises. In this regard, he added: researchers can use the biotechnology fund to implement their projects.

According to Ghanei, 12 groups have been supported in Parsis accelerator as the first accelerator in the area of medical biotechnology (medication and equipment) and regenerative medicine (stem cells), and we have aimed to increase the number of accelerators this year.

He also asserted: programs presented by accelerators often have limited duration and most of the times this duration is approximately three months. During this time, it is aimed to provide educational services, assets and workplace for idea owners to achieve their goals.